Deep Tech Startups

Neonode develops computer vision sensing and AI-driven in-cabin monitoring technology for the automotive industry, offering driver monitoring features such as fatigue detection and phone distraction alerts. The company licenses its technology to automotive OEMs, tier-one suppliers, and luxury car manufacturers to help them meet vehicle safety standards.

1 investor

Neotis develops immunotherapies to counteract age-related tissue decline by directing the immune system, with an initial focus on fibrotic disease. The company combines expertise in immunology, senescence, and biomarker development.

1 investor

NeoVac develops proprietary lipid technology for lipid nanoparticles (LNPs) designed to support mRNA-based therapeutics in vaccines, cancer immunotherapy, and autoimmune disease treatment. The company's lipid platform emphasizes tunable degradability to enhance safety and efficacy profiles.

1 investor

NEPESARK is a system semiconductor specialist company based in South Korea that designs and manufactures semiconductor products for various applications.

1 investor

Nesa builds a decentralized, trustless AI network that puts AI models on-chain so their performance can be tracked, verified, and controlled, combining privacy, security, verification, and consensus in an end-to-end system. It serves developers and organizations seeking open, decentralized AI, operating at the intersection of AI/ML and blockchain with its NES token.

1 investor

Nestria AI builds verification-first, model-agnostic agentic AI infrastructure for deploying governed AI across data- and IP-sensitive enterprise workflows, including hardware assurance, regulated financial systems, sovereign AI, and physical/embodied AI. Its platform combines LLMs, specialized agents, deterministic tools, and human-approval controls that can run on-premises, in private cloud, or in air-gapped environments.

1 investor

Net-Targets applies AI-enhanced systems biology to identify drug targets and mechanisms for pharmaceutical development. The company combines biological experimentation, mathematical modeling, and computer simulation to uncover hidden biological networks that inform medicine development.

1 investor

NET Energy develops thermal energy storage systems for liquid-cooled data centers, enabling peak shaving, steady-state cooling efficiency, and thermal backup power for high-density AI applications.

1 investor

Netform R&D is a technology solutions company serving South Korea's building renovation and maintenance markets through deep tech including vision-learning diagnostics, digital twin visualization, industrial safety AI, and eco-friendly materials research. The company provides end-to-end solutions spanning design, construction, safety, operations, and post-management phases across residential, commercial, and industrial properties.

1 investor

Netholabs is a research lab recording high-resolution neurobehavioural data from living systems and using it to train neural foundation models aimed at more sample-efficient AI, robotics, and personalized intelligence. It positions itself as building general intelligence grounded in biological systems.

1 investor

NETSOL manufactures serial STT-MRAM memory products in densities from 1Mb to 64Mb, designed for applications requiring fast data storage and retrieval with non-volatile characteristics. The products serve industrial designs and embedded systems needing code storage, data logging, and backup memory functionality.

1 investor

Netval is an Italian association, founded in 2002 and formalized in 2007, whose members include universities, public research bodies, and IRCCS institutes working on innovation and technology transfer. It supports the valorization of public research and maintains a community of technology-transfer office (TTO) managers.

1 investor

Neucore Bio develops precision therapeutics using engineered exosomes derived from fibroblasts to deliver molecular-level cellular repair and renewal across genetic and degenerative diseases with high unmet medical needs.

1 investor

NeuExcell Therapeutics is a clinical-stage gene therapy company developing treatments for neurodegenerative and neurological diseases such as glioma, Alzheimer's disease, and stroke. Its ATN (Astrocytes To Neurons) platform converts glial cells into functional neurons in vivo to repair damaged brain tissue.

1 investor

Neukio is a biopharmaceutical company developing iPSC-derived cell technology platforms and next-generation off-the-shelf, mass-producible immune cell products (such as NK cells) to treat solid tumors and autoimmune diseases. It focuses on innovation in both product and process development to lower cell therapy production costs and expand indication coverage.

1 investor

Getneuma builds the MouthPad, a custom-fit intraoral touchpad that lets users control cursors, clicks, scrolling, and dragging on computers, phones, and tablets through tongue, head, and breath gestures over Bluetooth. An MIT Media Lab spin-off focused on hands-free human augmentation and accessibility, it also offers VOX, a wearable microphone for quiet-speech dictation, and sells only within the United States.

1 investor

Neural Defend provides deepfake detection technology to protect people and organizations against synthetic media fraud. The company serves enterprises and individuals seeking to verify digital authenticity in an increasingly AI-generated content landscape.

1 investor

Neuralk builds foundational tabular AI models and autonomous agentic workflows that generate predictions (classification, regression, timeseries) on enterprise business data without requiring re-training. Its predictive AI is aimed at enterprises and data professionals across industries handling tabular data.

1 investor

NeuralTeks develops AI-powered tools for laboratory analysis, specifically targeting microbiology and microbial identification in pharmaceutical, biotechnology, and analytical settings. The platform aims to accelerate analysis speed, improve accuracy, and reduce costs for laboratory operations.

1 investor

Neuramancer is a Bavarian IT-security startup that builds forensic media-analysis software to detect deepfakes and AI manipulation in images and videos, including heavily compressed material from unknown sources. Its tools, offered as SaaS or on-premise with API integration and European hosting, serve fact-checkers, fraud investigators, analysts, and industries such as insurance and media.

1 investor

Neuramatix develops and licenses NeuraBase, a proprietary neural engine that builds memory-efficient adaptive neural networks modeled on biological brain function for tasks such as language translation, bioinformatics, robotic control, speech, and reinforcement learning. The technology is offered for research or commercial licensing across a range of AI and machine learning applications.

1 investor

Neuramill develops AI-based solutions for precision manufacturing, leveraging computer vision and machine learning. The company serves manufacturers and aims to improve production quality and efficiency through physical AI applications.

1 investor

Neurescue develops a medical device that treats cardiac arrest patients by inserting a balloon-occlusion device through the femoral artery to increase blood flow to the heart and brain during chest compressions. The device targets patients ineligible for defibrillation and uses automated pressure-limited inflation to improve resuscitation outcomes.

1 investor

Neurobiome LLC is developing the M.E. Gut-Brain chip, a microfluidic screening tool that uses dynamic flow and high-throughput testing to identify microbiome-mediated neuroactive compounds and probiotic strains. It targets early-stage screening for probiotic and pharmaceutical development aimed at mental and neurological health conditions.

1 investor